BPMC News and Press, Blueprint Medicines Corporation From 11/09/21

-- Zai Lab obtains exclusive rights to develop and commercialize BLU-945 and BLU-701 in Greater China -- -- Collaboration accelerates and expands global development of Blueprint Medicines’ next-generation EGFR inhibitors with plans to bring clinical trials of BLU-945 and BL...

Tango Therapeutics (NASDAQ:TNGX) has appointed Marc Rudoltz as the company’s new Chief Medical Officer. An alumnus of the Massachusetts Institute of Technology (MIT) and SUNY-Upstate Medical University, Rudoltz has over 20 years of experience in leading clinical-stage drug develop...

Image source: The Motley Fool. Blueprint Medicines Corp (NASDAQ: BPMC) Q3 2021 Earnings Call Oct 28, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Blueprint Medicines Corp (BPMC) Q3 2021 Earnings Call Transcript ...

Blueprint Medicines Corporation (BPMC) Q3 2021 Earnings Conference Call October 28, 2021 8:30 a.m. ET Company Participants Jeff Albers - CEO Mike Landsittel - CFO Christy Rossi - CCO Fouad Namouni - President, R&D Becker Hewes - CMO Kristin Hodous - IR Conference Call Participants Andrea ...

Blueprint Medicines  (NASDAQ:BPMC): Q3 GAAP EPS of -$2.00 misses by $0.37. Revenue of $24.19M (-96.8% Y/Y) misses by $18.39M. Guidance: The company expects to report full year 2021 total revenues in the range of $170-$180 million vs. consensus of $145.79 million. Press Release For furt...

Blueprint Medicines Reports Third Quarter 2021 Financial Results -- Strong AYVAKIT launch in advanced SM with $17.3 million in net product revenues in the first full quarter following U.S. approval -- -- Raising guidance for 2021 total revenue to $170-$180 million, based on ...

Blueprint Medicines to Report Third Quarter 2021 Financial Results on Thursday, October 28, 2021 PR Newswire CAMBRIDGE, Mass. , Oct. 21, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference call ...

Lone Pine Capital’s 13F portfolio value increased from $27.53B to $31.66B. The number of positions decreased from 38 to 36. They added Moderna, RH, and Twitter and increased Square and ServiceNow. Also, they dropped Mercadolibre, Netflix, Atlassian, Bilibili, and Snowflake. ...

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IDNA. A list of cheap stocks. For further details see: IDNA: Healthcare Dashboard For September

Blueprint Medicines to Present at Morgan Stanley 19th Annual Global Healthcare Conference PR Newswire CAMBRIDGE, Mass. , Sept. 2, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that Kate Haviland , Blueprint Medici...